A significant discovery in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer protector protein is frequently disabled in various forms of tumors, leading https://cyberbookmarking.com/story21858460/nanobodies-revive-tumor-suppressor-p53-a-new-pathway-for-tumor-treatment